More Anagenics Limited news
Anagenics LimitedASX: AN1

Key Midkine Antibody Patents Granted in the US and Europe

Jan 5, 2020 at 11:04 PM EST · Issued by Anagenics Limited

Filed with ASX · Jan 5, 2020 at 11:04 PM EST

On 6ix: 6ix.com/news/key-midkine-antibody-patents-granted-in-the-us-and-europe

Anagenics Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Anagenics Limited on 6ix

Story so far

  • New Evolis Distribution & Supply Agreements - China & EuropeOct 1, 2019
  • Patent for Improved Midkine Antibody Allowed in EuropeAug 22, 2019
  • New Patents for Midkine Antibodies in USA and EuropeNov 7, 2018

Earlier from Anagenics

  • Cellmid Reports on QVC SalesDec 5, 2019
  • Cellmid Signs Trading Agreement With API/PricelineNov 5, 2019
  • New TV Shopping Agreement for EvolisOct 13, 2019
  • New Evolis Distribution & Supply Agreements - China & EuropeOct 1, 2019
  • FY2019 Financial ResultsAug 28, 2019

Later from Anagenics

  • Appendix 4C and Notes to Appendix 4CJan 29, 2020
  • Cellmids Evolis Patent to be Granted in ChinaFeb 3, 2020
  • Appendix 4D, Half Year Accounts and PresentationFeb 26, 2020
  • Market Update on COVID-19Mar 27, 2020
  • Response to ASX Query LetterApr 6, 2020
All Anagenics news releases↗

Follow Anagenics into a list and get an email when it puts out news.

Follow Anagenics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer